Logo_ Header
What is Thalassemia? Treating Thalassemia Living with Thalassemia Cultural & Genetic Signifigance Clinical Trials & Research Support & Resources

search our site

Cord Blood Transplantation (2)

The Sibling Donor Cord Blood Program at Children's Hospital Oakland was developed to serve families of patients with thalassemia and sickle cell disease. The Center offers a variety of services, including:

  • outreach and recruitment
  • patient and family education
  • infectious disease screening
  • cord blood collection programs
  • genetic (HLA) typing
  • processing for long-term storage

What is cord blood stored and used for?
Cord blood is a rich source of stem cells, the same cells found in bone marrow. Stem cells are the parent cells which create all of a person's blood cells: red cells that carry oxygen, white cells that fight disease, and platelets that help blood to clot. Stem cells can be used to treat several life-threatening diseases which affect the blood system. Diseases such as thalassemia, sickle cell anemia and childhood leukemia may require stem cell transplantation to replace damaged, destroyed or improperly-functioning blood cells. Transplanting these cells offers hope to many patients.

Why should I save my infant's cord blood?
Having cord blood collected gives the family a chance to store the cord blood for potential future use. This is an important consideration, especially since cord blood units may be used in the absence of a perfect tissue match (called a human leukocyte antigen or HLA match). Therefore, the use of cord blood can provide a unique opportunity for a particular child, especially when the child's sibling is not a complete match. Having cord blood collected from a family member does not mean that a decision has been made to proceed with transplantation. It simply gives the family a chance to store cord blood for potential use.

Studies have also shown that there is a lower incidence of graft vs. host disease (GVHD) with cord blood transplants, probably due to the immaturity of the fetal cells. GVHD can range from moderate to severe in a transplant recipient, and can involve the skin, liver and/or gastrointestinal tract. <next>

<page 1> <page 2> <page 3> <page 4>

Northern Comprehensive Thalassemia Center
Standard of Care Home News & Events How you can help About Us